Bernard Fox: Wonderful video that includes Jeffrey Weber’s advice to his younger self
Bernard Fox shared a post on LinkedIn:
“Young Academic Clinical Investigators Watch this video!! Thanks OncoDaily for posting this story. I am reposting to call attention to the video included in OncoDaily’s Blog.
This is a wonderful video that includes Jeff’s advice to his younger self. Society for Immunotherapy of Cancer (SITC) recorded this when Jeff was inducted as a Fellow of the Academy of Immunotherapy-Oncology.”
Source: Bernard Fox/LinkedIn
Honoring Jeff Weber, a giant in the field of oncology
Bernard A. Fox is the Co-Founder, President, and CEO of UbiVac. He is an Adjunct Professor in the Department of Molecular Microbiology and Immunology, at the Knight Cancer Institute. He is also a Member of Board of Directors at Oregon Bioscience Association. In 2012, Dr. Fox received the Harder Family Endowed Chair for Cancer Research in recognition of his efforts in translational cancer therapy.
Jeffrey S. Weber, MD, PhD, a 2016 Giants of Cancer Care awardee in Melanoma, held several prominent roles, including Deputy Director of the Laura and Isaac Perlmutter Cancer Center, the Laura and Isaac Perlmutter Professor of Oncology in the Department of Medicine at New York University (NYU) Grossman School of Medicine, director of the Experimental Therapeutics Program, and co-leader of the Clinical Melanoma Program Board at NYU Langone Health.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023